This is a numbers-first look at Colgate Palmolive (India) Ltd. (COLPAL), covering income trends, margins, valuation, and shareholding.
Colgate Palmolive Revenue Trend
For FY2025, Colgate Palmolive (India) Ltd. recorded revenue of ₹6,179 Cr. That's 7.3% higher than the ₹5,757 Cr it brought in during FY2024.
The 10-year revenue CAGR of 4.5% is on the lower side. Colgate Palmolive (India) Ltd.'s top line moved from ₹3,982 Cr to ₹6,179 Cr, but real growth has been thin.
At ₹6,179 Cr in annual revenue, Colgate Palmolive (India) Ltd. is one of the mid-sized players in the personal care space.
With 7 straight years of revenue growth, this isn't a blip — the trajectory is clear for Colgate Palmolive (India) Ltd..
| Year | Revenue | YoY % |
|---|---|---|
| FY2025 | ₹6,179 Cr | +7.3% |
| FY2024 | ₹5,757 Cr | +9.0% |
| FY2023 | ₹5,280 Cr | +3.0% |
| FY2022 | ₹5,126 Cr | +5.2% |
| FY2021 | ₹4,872 Cr | — |
View Colgate Palmolive (India) Ltd.'s full 10-year revenue trend with CAGR analysis →
Colgate Palmolive Profitability
A 8.5% improvement in net profit took Colgate Palmolive (India) Ltd.'s bottom line to ₹1,437 Cr in FY2025.
On the margin front, things were flat — net profit margin stayed around 23.3% in FY2025.
At ₹52.83 per share (diluted), FY2025 earnings were up year-over-year from ₹48.67.
Is Colgate Palmolive Undervalued
Running the numbers through the P/E Ratio model gives a fair value of ₹2,305 for Colgate Palmolive (India) Ltd..
Colgate Palmolive (India) Ltd. shares are currently trading at ₹2,018.60.
Craytheon also calculates intrinsic value using the EPS Growth and DCF models. The full breakdown with assumptions is available in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹2,305 | 14.2% upside to fair value |
| EPS Growth | Upgrade | Upgrade |
| DCF | Upgrade | Upgrade |
See all valuation models for Colgate Palmolive (India) Ltd. with detailed assumptions →
Colgate Palmolive Shareholding Pattern
Promoter holding is steady at 51.0% — no buying or selling over the past 4 quarters.
As of March 2026, FIIs own 13.6% of the company — down from 20.4% a year earlier.
DII ownership is at 15.5%, up from the 9.6% recorded a year ago.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Mar 2026 | 51.0% | 13.6% | 15.5% | 19.9% |
| Dec 2025 | 51.0% | 15.2% | 13.8% | 20.0% |
| Sep 2025 | 51.0% | 17.2% | 12.2% | 19.6% |
| Jun 2025 | 51.0% | 20.4% | 9.6% | 19.0% |
Track quarterly shareholding changes for Colgate Palmolive (India) Ltd. →
Colgate Palmolive Balance Sheet
Proportional view as of 3 Jun 2026. Hover blocks for details.
Assets
Liabilities & Equity
Total assets stood at ₹30.07B at the end of FY2025, down 5.9% from ₹31.97B a year earlier.
Cash & ST Investments is the largest block at 36.4%, followed by Property, Plant & Equipment at 27.1% and Other Assets at 16.4%.
Equity makes up 55.1% of liabilities and equity, with debt at 2.0% and operating liabilities at 42.8%. Over the year, debt is down 15.2% and equity is down 11.2%.
Balance sheet composition — FY 2025
| Category | Value |
|---|---|
| Cash & ST Investments | 10.95B |
| Receivables | 2.26B |
| Inventories | 3.77B |
| Property, Plant & Equipment | 8.15B |
| Other Assets | 4.94B |
| Category | Value |
|---|---|
| Equity | 16.64B |
| Short-term Debt | 154.10M |
| Long-term Debt | 454.30M |
| Trade Payables | 9.21B |
| Other Liabilities | 3.72B |
Colgate Palmolive Stock Analysis
To sum up Colgate Palmolive (India) Ltd.'s financial position: the data paints a clear picture for investors evaluating this personal care stock.
Revenue of ₹6,179 Cr in FY2025, up 7.3% year-over-year.
Long-term revenue has been compounding at 4.5% annually over 10 years.
The company is profitable, with a net margin of 23.3% and net income of ₹1,437 Cr.
The P/E Ratio model implies 14.2% upside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
For the complete 10-year financial history with interactive charts and growth analysis, explore Colgate Palmolive (India) Ltd.'s detailed profile on Craytheon.